3,003
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis

, , , , , , , & show all
Pages 184-191 | Received 05 Jan 2017, Accepted 12 Feb 2017, Published online: 03 Apr 2017

References

  • Wong SY, Woo J, Leung JC, et al. Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in southern Chinese men: a prospective study. Aging Male 2010;13:113–9.
  • Asiedu B, Anang Y, Nyarko A, et al. The role of sex steroid hormones in benign prostatic hyperplasia. Aging Male 2017;13:1–6; doi:10.1080/13685538.2016.1272101. [Epub ahead of print]
  • Kaplan SA, O'Neill E, Lowe R, et al. Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS). Aging Male 2013;16:48–51.
  • Nakamura M, Fujimura T, Nagata M, et al. Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires. Aging Male 2012;15:111–4.
  • Aktas BK, Gokkaya CS, Bulut S, et al. Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients. Aging Male 2011;14:48–52.
  • Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75–9.
  • Holtgrewe HL, Mebust WK, Dowd JB, et al. Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol 1989;141:248–53.
  • Dunsmuir WD, Emberton M. National Prostatectomy Audit Steering Group. There is significant sexual dysfunction following TURP. Br J Urol 1996;77:39–40 (Abstract)
  • Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989;141:243–7.
  • Wendt-Nordahl G, Häcker A, Reich O, et al. The vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol 2004;46:586–90.
  • Rassweiler J, Schulze M, Stock C, et al. Bipolar transurethral resection of the prostate technical modifications and early clinical experience. Minim Invasive Ther Allied Technol 2007;16:11–21
  • Chun SS, Razvi HA, Denstedt JD. Laser prostatectomy with the holmium: YAG laser. Tech Urol 1995;1:217–21.
  • Gilling GJ, Cass CB, Malcolm AR, Fraundorfer MR. Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 1995;9:151–3.
  • Gilling PJ, Mackey M, Cresswell M, et al. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year follow-up. J Urol 1999;162:1640–4.
  • Matsuoka K, Iida S, Tomiyasu K, et al. Transurethral holmium laser resection of the prostate. J Urol 2000;163:515–8.
  • Chilton CP, Mundy IP, Wiseman O. Results of holmium laser resection of the prostate for benign prostatic hyperplasia. J Endourol 2000;14:533–4.
  • Clarke M, Horton R. Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet 2001;357:1728.
  • Fayad AS, EI Sheikh MG, Zakaria T, et al. Holmium laser enucleation versus bipolar resection of the prostate: a prospective randomized study. Which to choose? J Endourol 2011;25:1347–52.
  • Neill MG, Gilling PJ, Kennett KM, et al. Randomized trial comparing holmium laser enucleation of prostate with plasm-akinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 2006;5:1020–4.
  • Chen Y, Chen Q, Wang Z, et al A prospective, randomized clinical trial comparing plasm-akinetic resection of the prostate with holmium laser enucleation of the prostate based on a 2-year follow up. J Urol 2013;189:217–22.
  • Zhu Q, Gu X, Yuan L, et al. TUBVP and HOLEP: desirable surgical options for large benign prostatic hyperplasia (>80 ml). Natl J Androl 2008;14:907–10.
  • Pajovic B, Radojevic N, Dimitrovski A, et al. The therapeutic potential of royal jelly in benign prostatic hyperplasia. Comparison with contemporary literature. Aging Male 2016;19:192–6.
  • Salah Azab S, Elsheikh MG. The impact of the bladder wall thickness on the outcome of the medical treatment using alpha-blocker of BPH patients with LUTS. Aging Male 2015;18:89–92.
  • Rassweiler J, Teber D, Rainer Kuntz, Rainer Hofmann. Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 2006;50:969–80.
  • ElMalik EM, Ibrahim AI, Gahli AM, et al. Risk factors in prostatectomy bleeding: preoperative urinary infection is the only reversible factor. Eur Urol 2000;37:199–204.
  • Rieken M, Bachmann A, Shariat SF. Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time? Curr Opin Urol 2016;26:22–7.
  • Cornu JN. Bipolar, monopolar, photovaporization of the prostate, or holmium laser enucleation of the prostate: how to choose what's best? Urol Clin North Am 2016;43:377–84.
  • Fayad AS, Elsheikh MG, Zakaria T, et al. Holmium laser enucleation of the prostate versus bipolar resection of the prostate: a prospective randomized study. “pros and cons”. Urology 2015;86:1037–41.
  • Cornu JN, Ahyai S, Bachmann A, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 2015;67:1066–96.
  • Chen Q, Zhang L, Fan QL, et al. Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU Int 2010;106:1339–43.
  • Ho HS, Yip SK, Lim KB, et al. A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 2007;52:517–22.
  • Fagerström T, Nyman CR, Hahn RG. Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single center randomized trial of 202 patients. BJU Int 2009;105:1560–4.
  • Miki M, Shiozawa H, Matsumoto T, Aizawa T. Transurethral resection in saline (TURis): a newly developed TUR system preventing obturator nerve reflex. Nippon Hinyokika Gakkai Zasshi 2003;94:671–7.
  • Shiozawa H, Aizawa T, Ito T, et al. A new transurethral resection system: operating in saline environment precludes obturator nerve reflexes. J Urol 2002;168:2665–7.
  • Chen Q, Zhang L, Liu YJ, et al. Bipolar transurethral resection in saline system versus traditional monopolar resection system in treating large-volume benign prostatic hyperplasia. Urol Int 2009;83:55–9.
  • Cynk M. Holmium laser enucleation of the prostate: a review of the clinical trial evidence. Ther Adv Urol 2014;6:62–73.
  • Mavuduru RM, Mandal AK, Singh SK, et al. Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and peri-operative morbidity. Urol Int 2009;82:130–5.
  • Tan A, Liao C, Mo Z, Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 2007;94:1201–8.
  • Gupta NP, Nayyar R. Management of large prostatic adenoma: lasers versus bipolar transurethral resection of prostate. Indian J Urol 2013;29:225–35.
  • El-Hakim A, Elhilali MM. Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 2002;90:863–9.
  • Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 2007;52:1456–64.
  • Coban S, Doluoglu OG, Keles I, et al. Age and total and free prostate-specific antigen levels for predicting prostate volume in patients with benign prostatic hyperplasia. Aging Male 2016;19:124–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.